Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model
Autor: | Zhi-yong Qin, Xian-cheng Chen, Hongzhi Xu, Yu-xiang Gu, Ping Zhou |
---|---|
Rok vydání: | 2011 |
Předmět: |
Subarachnoid hemorrhage
Swine medicine.medical_treatment Streptokinase Cisterna magna Cerebral vasospasm Fibrinolytic Agents medicine.artery Basilar artery medicine Animals Vasospasm Intracranial cardiovascular diseases Saline medicine.diagnostic_test business.industry Vasospasm Subarachnoid Hemorrhage medicine.disease Recombinant Proteins Cerebral Angiography nervous system diseases Disease Models Animal Basilar Artery Oxyhemoglobins Anesthesia Chronic Disease Angiography cardiovascular system Surgery Neurology (clinical) business medicine.drug |
Zdroj: | Acta Neurochirurgica. 153:1333-1338 |
ISSN: | 0942-0940 0001-6268 |
Popis: | After subarachnoid hemorrhage (SAH), the formation of subarachnoid clots and their associated resolution may be involved in the development of chronic cerebral vasospasm. To dissolve and wash out the subarachnoid clot is one of the therapeutic strategies for prevention of cerebral vasospasm. We investigated the effect of recombinant streptokinase (r-SK), a synthetic plasminogen activator, which is added to degenerate oxyhemoglobin, one of the strongest spasmogenic substances. The efficacy and safety of this therapy concerning the development of chronic cerebral vasospasm were evaluated in a swine model. Eighteen healthy porcine subjects were used. Each was randomly assigned to one of three groups: saline control (A), SAH treated with saline (B), and r-SK injection into the cisterna magna (C). SAH was produced by introduction of blood clots into the cisterna magna on each of 2 days in all subjects in groups B and C. At 24-h post-SAH, a one-time dosage of 15 mg of r-SK was administered to those subjects randomized to group C. Continuous drainage was applied in all three groups. Vessel diameter was evaluated by angiography before the induction of SAH and at day 7 following SAH. The pre- and post-SAH angiographs of subjects in group A determined no significant difference in mean vessel caliber. In group B, pre- and post-SAH angiography indicated significant (p |
Databáze: | OpenAIRE |
Externí odkaz: |